Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional vitamin D3 plus cryotherapy vs cryotherapy alone for cutaneous warts
IRCT20230124057201N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vitamin d in verruca (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Wart clearance rate. Started Aug 2023; status: completed.
02
Drugs
vitamin d
03
Conditions
verruca
Beyond the preview
Go deeper on IRCT20230124057201N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230124057201N3.